David Raben

Chief Medical Officer, Bicara Therapeutics Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Apr 27, 2026Sold 5,500 shares at $22.88 of Bicara Therapeutics Inc.²
Apr 27, 2026Exercised options 5,500 shares at $3.79 of Bicara Therapeutics Inc.²
Mar 25, 2026Sold 5,500 shares at $18.95 of Bicara Therapeutics Inc.³
Mar 25, 2026Exercised options 5,500 shares at $3.79 of Bicara Therapeutics Inc.³
Mar 4, 2026Sold 16,300 shares at $18.52 of Bicara Therapeutics Inc.⁴
Mar 4, 2026Exercised options 16,300 shares at $3.79 of Bicara Therapeutics Inc.⁴
Mar 3, 2026Sold 200 shares at $18.45 of Bicara Therapeutics Inc.⁴
Mar 3, 2026Exercised options 200 shares at $3.79 of Bicara Therapeutics Inc.⁴
Dec 26, 2025Exercised options 19,789 shares at $3.79 of Bicara Therapeutics Inc.⁵
Nov 25, 2025Sold 906 shares at $18.84 of Bicara Therapeutics Inc.⁶
Nov 25, 2025Exercised options 906 shares at $3.79 of Bicara Therapeutics Inc.⁶
Nov 25, 2025Sold 4,594 shares at $18.84 of Bicara Therapeutics Inc.⁶
Nov 25, 2025Exercised options 4,594 shares at $3.79 of Bicara Therapeutics Inc.⁶
Nov 24, 2025Sold 5,500 shares at $18.45 of Bicara Therapeutics Inc.⁶
Nov 24, 2025Exercised options 5,500 shares at $3.79 of Bicara Therapeutics Inc.⁶
Oct 9, 2025Sold 22,000 shares at $18.45 of Bicara Therapeutics Inc.⁷
Oct 9, 2025Exercised options 22,000 shares at $3.79 of Bicara Therapeutics Inc.⁷

The numbers on this page point here. Each one links to the record it came from.